AntineoplasticsLack of efficacy, and fatigue and thrombocytopenia following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1919卷 / 1期

关键词：

D O I：

10.1007/s40278-022-21013-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：71 / 71

相关论文

共 50 条

[1] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1866 (1) : 47 - 47
[2] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1857 (1) : 44 - 44
[3] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1883 (1) : 45 - 45
[4] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1871 (1) : 52 - 52
[5] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1943 (1) : 84 - 84
[6] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1951 (1) : 49 - 49
[7] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1838 (1) : 56 - 56
[8] AntineoplasticsLack of efficacy, treatment failure and off-label use: case report
[J]. Reactions Weekly, 2022, 1926 (1) : 63 - 63
[9] AntineoplasticsLack of efficacy, off-label use and various toxicities: case report
[J]. Reactions Weekly, 2023, 1967 (1) : 47 - 47
[10] AntineoplasticsLack of efficacy, and hand-foot syndrome following off-label use: case report
[J]. Reactions Weekly, 2022, 1927 (1) : 65 - 65

← 1 2 3 4 5 →